HOOKIPA Pharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
HOOKIPA Pharma Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • HOOKIPA Pharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $89.3M, a 35.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $89.3M +$23.5M +35.8% Dec 31, 2023 10-K 2024-03-22
Q4 2022 $65.8M +$12M +22.4% Dec 31, 2022 10-K 2024-03-22
Q4 2021 $53.7M +$7.66M +16.6% Dec 31, 2021 10-K 2024-03-22
Q4 2020 $46.1M +$13.5M +41.4% Dec 31, 2020 10-K 2024-03-22
Q4 2019 $32.6M +$13.4M +70.1% Dec 31, 2019 10-K 2023-03-15
Q4 2018 $19.2M +$5.37M +38.9% Dec 31, 2018 10-K 2022-03-24
Q4 2017 $13.8M +$5.41M +64.6% Dec 31, 2017 10-K 2021-03-18
Q4 2016 $8.38M Dec 31, 2016 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.